|
2
|
|
Chemogenetic ubiquitin E1 inhibitor TAK-243 CRISPR screen uncovers HAPSTR1/HUWE1 axis in chromatin proteostasis and cell cycle control.
(science.org)
|
van Overbeek NK
…
Vertegaal ACO
Science Advances
2026-10-16
|
#crispr
#ubiquitination
#proteostasis
#cell cycle
#cancer
|
|
2
|
|
Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer.
(linkinghub.elsevier.com)
|
Liu S
…
Xu M
Cell Reports Medicine
2026-10-16
|
#cancer
#immunotherapy
#immunity
#senescence
#metabolism
|
|
4
|
|
AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes.
(nature.com)
|
Luebeck J
…
Bafna V
Nature Methods
2026-10-16
|
#cancer
#amplification
#sequencing
#oncogene
#extrachromosomal
|
|
2
|
|
NKG2D overexpression potentiates CAR-T cells through costimulation by tumor NKG2D ligands.
(linkinghub.elsevier.com)
|
Li J
…
Han W
Cell Reports Medicine
2026-10-16
|
#immunotherapy
#car-t
#cancer
#activation
#exhaustion
|
|
1
|
|
Lipid-based mRNA chimeric antigen receptor T cells for enhanced in vitro antitumor activity.
(linkinghub.elsevier.com)
|
Gao H
…
Qian Q
iScience
2026-10-16
|
#immunotherapy
#rna
#lipid nanoparticles
#cancer
#transfection
|
|
1
|
|
BUB signaling in cancer and molecular insights into targeted therapies.
(nature.com)
|
Baweja B
…
Nema R
Communications Biology
2026-10-16
|
#cancer
#cell cycle
#targeted therapy
#chromosomal instability
#biomarker
|
|
2
|
|
Programmable and selective silencing of oncogenic fusion transcripts by CRISPR-Cas13b via breakpoint sequence recognition.
(science.org)
|
Hu 胡文欣 W
…
Fareh M
Science Advances
2026-10-16
|
#crispr
#fusion
#cancer
#leukemia
#transcriptomics
|
|
2
|
|
Therapeutic-scale CAR-NK microrobots with programmable swarm navigation for targeted solid tumor therapy.
(science.org)
|
Wu Z
…
Zhao J
Science Advances
2026-10-16
|
#cancer
#immunotherapy
#nanoparticles
#microrobots
#engineering
|
|
1
|
|
IPO5 contributes to cetuximab resistance in colorectal cancer by modulating Ras signaling.
(linkinghub.elsevier.com)
|
Yuan Q
…
Li X
iScience
2026-10-16
|
#amr
#cancer
#cetuximab
#signaling
#apoptosis
|
|
6
|
|
One structural class, one treatment? Firmonertinib in PACC-mutant NSCLC.
(linkinghub.elsevier.com)
|
Huang DD
…
Yang JC
Cancer Cell
2026-10-16
|
#cancer
#nsclc
#tyrosine kinase inhibitor
#targeted therapy
|